Latest News

Cost-effectiveness of treatments in neurological diseases

Professor Dyfrig Hughes and colleagues at the Centre for Health Economics and Medicines Evaluation, School of Health Sciences, have recently published the results of three clinical trials of interventions in epilepsy and sciatica.

Publication date: 21 April 2021

Treatment of chloroquine poisoning

Research by Bangor University’s Professor Dyfrig Hughes has provided important evidence on the safety of treatments that are being tested for use in COVID-19.

Publication date: 28 May 2020

Research involving Bangor University with relevance full recovery for Covid-19 patients cited by European Parliament

Research by Professor Dyfrig Hughes of the Centre for Health Economics and Medicines Evaluation in School of Health Sciences into the economic impact of chronic fatigue syndrome (CFS) - also known as myalgic encephalomyelitis (ME) – was published recently in the journal Healthcare.

Publication date: 7 May 2020

Exercise: we calculated its true value for older people and society

Taking up exercise is one of the most popular New Year’s resolutions for people wanting to improve their health. But our research shows that the benefits of older people going to exercise groups go beyond self-improvement and provide good value for society, too. This article by Carys Jones , Research Fellow in Health Economics at the Centre for Health Economics and Medicines Evaluation is republished from The Conversation under a Creative Commons license. Read the original article .

Publication date: 9 January 2020

Wales could save billions of pounds a year through investing in a healthier workforce

A new report by the Centre for Health Economics and Medicines Evaluation ( CHEME ), Bangor University has brought together evidence of the economic arguments for investing in the health and wellbeing of the workforce in Wales.

Publication date: 17 October 2019